UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054211
Receipt number R000061901
Scientific Title Long-term impact of lateral truncal tilt training in sitting position with a wedge on learning postural control in patients with hemiplegia: A double-blind, randomized, crossover controlled trial.
Date of disclosure of the study information 2024/04/22
Last modified on 2024/04/21 12:26:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term impact of lateral truncal tilt training in sitting position with a wedge on learning postural control in patients with hemiplegia: A double-blind, randomized, crossover controlled trial.

Acronym

Long-term impact of lateral truncal tilt training in sitting position with a wedge on learning postural control in patients with hemiplegia: A double-blind, randomized, crossover controlled trial.

Scientific Title

Long-term impact of lateral truncal tilt training in sitting position with a wedge on learning postural control in patients with hemiplegia: A double-blind, randomized, crossover controlled trial.

Scientific Title:Acronym

Long-term impact of lateral truncal tilt training in sitting position with a wedge on learning postural control in patients with hemiplegia: A double-blind, randomized, crossover controlled trial.

Region

Japan


Condition

Condition

Cases with hemiplegia, pusher behavior and unilateral spatial neglect

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to determine the effects of the long-term impact of lateral truncal tilt training on learning postural control in patients with hemiplegia, pusher behavior, and unilateral spatial neglect.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

center of pressure; CoP
Brain activity

Key secondary outcomes

Scale for contraversive Pushing; SCP
Trunk Control Test; TCT
Berg Balance Scale; BBS
Functional Independence Measure; FIM


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Specific trining; wedge training

Interventions/Control_2

Conventional training; without wedge training

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

The inclusion criteria are being able to sit when observing a person and having suffered the first-ever stroke.

Key exclusion criteria

The exclusion criteria are cerebellar lesions, multiple cerebral infarctions, poor instruction comprehension, and orthopedic history.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kota
Middle name
Last name Sawa

Organization

SBC Tokyo Medical University

Division name

Department of Physical Therapy, Faculty of Health Sciences

Zip code

279-8567

Address

5-8-1 Akemi, Urayasu, Chiba, Japan

TEL

+03-80-1207-9205

Email

k-sawa@sbctmu.ac.jp


Public contact

Name of contact person

1st name Kota
Middle name
Last name Sawa

Organization

SBC Tokyo Medical University

Division name

Department of Physical Therapy, Faculty of Health Sciences

Zip code

279-8567

Address

5-8-1 Akemi, Urayasu, Chiba, Japan

TEL

08012079205

Homepage URL


Email

k-sawa@sbctmu.ac.jp


Sponsor or person

Institute

SBC Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

SBC Tokyo Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SBC Tokyo Medical University

Address

5-8-1, Akemi, Urayasu, Chiba, Japan, 279-8567

Tel

08012079205

Email

k-sawa@sbctmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 04 Month 19 Day

Date of IRB

2024 Year 04 Month 19 Day

Anticipated trial start date

2024 Year 04 Month 22 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 21 Day

Last modified on

2024 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name